drug

Antipsychotic treatment discontinuation

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Fundación Marques de Valdecilla
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

2
10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
NCT03090490—Unknown
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
NCT02220504—Completed

KOLs & investigators

1
Benedicto Crespo-Facorro, ProfessorKOL score 12

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Fundación Marques de Valdecilla
company
trial
10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
NA
trial
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
NA
trial
indication
Schizophrenia
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Schizophrenia
indication
Schizophrenia Relapse
indication
KOL
Benedicto Crespo-Facorro, Professor
KOL score 12
person